UK Markets open in 1 hr 26 mins

Bionano Genomics, Inc. (BNGO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.8100-0.0200 (-1.09%)
At close: 04:00PM EST
1.7991 -0.01 (-0.60%)
After hours: 07:58PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.26
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 34.3500
52-week low 31.1600
50-day moving average 31.9334
200-day moving average 31.9701

Share statistics

Avg vol (3-month) 37.46M
Avg vol (10-day) 37.61M
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 8284.54M
% held by insiders 11.91%
% held by institutions 128.86%
Shares short (13 Oct 2022) 446.73M
Short ratio (13 Oct 2022) 48.15
Short % of float (13 Oct 2022) 416.11%
Short % of shares outstanding (13 Oct 2022) 416.10%
Shares short (prior month 14 Sept 2022) 440.99M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-471.57%

Management effectiveness

Return on assets (ttm)-20.27%
Return on equity (ttm)-33.56%

Income statement

Revenue (ttm)23.32M
Revenue per share (ttm)0.08
Quarterly revenue growth (yoy)73.00%
Gross profit (ttm)3.87M
EBITDA -103.12M
Net income avi to common (ttm)-105.81M
Diluted EPS (ttm)-0.3940
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)187.34M
Total cash per share (mrq)0.65
Total debt (mrq)10.76M
Total debt/equity (mrq)3.78
Current ratio (mrq)7.75
Book value per share (mrq)0.19

Cash flow statement

Operating cash flow (ttm)-106.43M
Levered free cash flow (ttm)-50.65M